Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD

NCT03693560 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Diabetes Mellitus, Type 2

Interventions

DRUG: Vildagliptin 50 mg Oral Tablet
DRUG: Metformin 1000 mg Oral Tablet
DRUG: Glimepiride upto 4 mg Oral Tablet

Sponsor

Damanhour University

Collaborators

[object Object]